peroxynitrous acid has been researched along with atorvastatin in 4 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (atorvastatin) | Trials (atorvastatin) | Recent Studies (post-2010) (atorvastatin) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 7,420 | 2,058 | 3,782 |
Protein | Taxonomy | peroxynitrous acid (IC50) | atorvastatin (IC50) |
---|---|---|---|
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0064 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 0.0002 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0002 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0054 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.3 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hassan, MK; Heeba, G; Khalifa, M; Malinski, T | 1 |
Day, CA; Funovics, P; Heeba, G; Jacob, RF; Kubant, R; Malinski, T; Mason, RP; Medlin, YS | 1 |
Gryglewski, R; Hassan, M; Heeba, G; Khalifa, M; Malinski, T; Moselhy, ME | 1 |
Corbalan, JJ; Dawoud, H; Jacob, RF; Malinski, T; Mason, RP | 1 |
4 other study(ies) available for peroxynitrous acid and atorvastatin
Article | Year |
---|---|
Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Topics: Acetophenones; Atorvastatin; Calcimycin; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pyrroles; Simvastatin | 2007 |
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.
Topics: Amlodipine; Atorvastatin; Blotting, Western; Calcium Channel Blockers; Cells, Cultured; Drug Synergism; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Bilayers; Lipoproteins, LDL; Membrane Lipids; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pyrroles; Vascular Diseases; X-Ray Diffraction | 2008 |
Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1.
Topics: Animals; Aorta; Arginine; Atherosclerosis; Atorvastatin; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Heme Oxygenase-1; Hemin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Metalloporphyrins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Protoporphyrins; Pyrroles; Rabbits; Simvastatin; Time Factors | 2009 |
Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Glucose; Blood Pressure; Chemokine CCL5; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Rats, Inbred SHR | 2015 |